Sculptor Capital LP Astrazeneca PLC Transaction History

Sculptor Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $45.8 Million - $55 Million	-772,960 Reduced 91.98%	67,371 $4.45 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $28.7 Million - $34.6 Million	515,507 Added 158.7%	840,331 $55.7 Million
Q4 2021 Feb 11, 2022	BUY	$54.02 - $63.83 $4.21 Million - $4.97 Million	77,938 Added 31.57%	324,824 $18.9 Million
Q1 2019 May 13, 2019	BUY	$35.49 - $43.02 $8.76 Million - $10.6 Million	246,886 New	246,886 $0

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.